This Week in Nature

In Nature this week, a multi-institute team of scientists publishes a comprehensive analysis of somatic mutations across whole-genome sequences for breast cancer. They sequenced the full genomes of tumors and normal tissue from 560 breast cancer patients across both coding and non-coding regions, and identified several mutational signatures associated with defective DNA repair and tumor suppressor gene function.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.